Mannitol and dopamine in patients undergoing cardiopulmonary bypass: a randomized clinical trial.


Journal Article

UNLABELLED:In this prospective, randomized, placebo-controlled, double-blinded study, we determined the effects of two commonly used adjuncts, mannitol and dopamine, on beta(2)-microglobulin (beta(2)M) excretion rates in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass (CPB). beta(2)M excretion rate has been described as a sensitive marker of proximal renal tubular function. One-hundred patients with a preoperative serum creatinine level

Full Text

Cited Authors

  • Carcoana, OV; Mathew, JP; Davis, E; Byrne, DW; Hayslett, JP; Hines, RL; Garwood, S

Published Date

  • November 2003

Published In

Volume / Issue

  • 97 / 5

Start / End Page

  • 1222 - 1229

PubMed ID

  • 14570627

Pubmed Central ID

  • 14570627

Electronic International Standard Serial Number (EISSN)

  • 1526-7598

International Standard Serial Number (ISSN)

  • 0003-2999

Digital Object Identifier (DOI)

  • 10.1213/01.ane.0000086727.42573.a8


  • eng